Executive Summary
162 corporate events are scheduled for May 28, 2026: 156 financial results and 6 board meetings. Companies on the calendar include Aban Offshore Limited, A B Infrabuild Limited, Aegis Vopak Terminals Limited, Ajooni Biotech Limited, Aksh Optifibre Limited, Alkem Laboratories Limited and 154 others.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior India Quarterly Results BSE NSE Announcements digest from May 27, 2026.
Scheduled Events (162)
Companies with corporate events on the calendar for this day.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the quarter and year ended March 31, 2026 and recommendation of final dividend if any for the FY 2025-26
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 28th May, 2026, inter alia:(i) To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2026; and (ii) To consider and recommend Final Dividend, if any, for financial year ended 31st March, 2026.
Intimation of Board Meeting inter-alia to consider, approve and take on record the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31, 2026 along with the Statutory Auditors' Report thereon and to consider and recommend payment of Final Dividend on Equity Shares of the Company for FY 2025-26, for the approval of Shareholders at the ensuing 51st Annual General Meeting of the Company.
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and to take on record the Audited Standalone & Consolidate Financial Results of the Company for the Quarter and the year ended 31st March, 2026, to consider & recommend dividend, if any and the matters incidental thereto.
To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results (standalone & Consolidated) for the quarter and year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the audited financial results (Standalone and Consolidated) for the fourth quarter and financial year ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the audited standalone financial results for the quarter and year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the Audited financial results for the period ended March 31, 2026 and other business matters.
DCM Limited has informed that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Audited Financial Results for the Quarter and Year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
ECOSMOBLTY : 28-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 25, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 28, 2026, To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Audited Financial Results of the Company for the Financial Year ended 31st March, 2026 and recommendation of Dividend, if any, for the Financial Year 2025-26.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Gaudium IVF and Women Health Limited has informed the Exchange that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026, inter alia, to consider and approve the Audited Standalone and Consolidated Financial Statements/Results of the Company for the quarter and year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the audited financial results for the quarter and year ended March 31, 2026 and other matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026, Fund Raising and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026
INNOVISION : 28-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 25, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 28, 2026, To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the quarter and financial year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and interim dividend if any, on the equity shares of the Company.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the audited financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend if any
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the Audited (Standalone & Consolidated) financial results for the Quarter and Year ended March 31, 2026 and recommendation of dividend on equity shares of the Company, if any.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
Intimation of Board Meeting scheduled to be held on Thursday, May 28, 2026 to consider and approve inter alia the following agenda items: Audited Financial Results (Standalone and Consolidated) for the 4th Quarter and Financial Year ended March 31, 2026 Recommendation of declaration of dividend, if any on the Equity Shares of the Company for the Financial Year 2025-26.
MADHUCON : 28-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 25, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 28, 2026, To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial year ended 31st March 2026, to recommend payment of dividend, and any other matter with the permission of the Chairman.
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the Audited financial results for the period ended March 31, 2026 and may recommend Dividend.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
MMTC intimates the Stock Exchange about the Board Meeting to be held on 28.05.2026 (Thursday) to consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
NAHAR SPINNING MILLS LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2026 to consider and approve the Yearly Audited Financial results of the Company and Dividend, if any for the financial year ended March 2026.
Prior Intimation of the Board meeting pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March, 2026
To consider and approve the financial results for the period ended March 31, 2026, distribution and Fund Raising
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve Audited Financial Statements for the Financial Year ending on March 31, 2026 and recommendation of final dividend, if any
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and Scheme of Amalgamation and other business matters
to consider and approve the Audited Financial Results for the quarter and year ended 31st March 2026 and to discuss the matter of recommendation of a dividend, if any, for the financial year ending 31st March 2026.
To consider and approve the financial results for the quarter & financial year ended on March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve Audited Standalone and Consolidated financial results of the Company for the quarter and financial year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026.
To consider and approve the audited financial results for the quarter and year ended March 31, 2026
To Consider And Approve The Standalone And Consolidated Audited Financial Results Of The Company Along With The Audited Report For The Quarter And Financial Year Ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters.
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026.
Source: company filings and exchange event calendars. Times shown in local market time when published.
Get daily alerts with full AI analysis of all 162 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Quarterly Results BSE NSE Announcements
🇮🇳 More from India
View all →June 01, 2026
India Pre-Market Regulatory Roundup — June 01, 2026
India Pre-Market Regulatory Roundup
May 31, 2026
India Pre-Market Regulatory Roundup — May 31, 2026
India Pre-Market Regulatory Roundup
May 31, 2026
India MCA Corporate Compliance Enforcement — May 31, 2026
India MCA Corporate Compliance Enforcement
May 31, 2026
India RBI Banking Regulatory Enforcement Actions — May 31, 2026
India RBI Banking Regulatory Enforcement Actions